It is with great pride that we can announce that the first two of the MELGEN early stage researchers have successfully completed their PhD studies and passed their PhD Dissertation (also known as a Thesis) defence interviews (referred to in the UK as a Viva).
Dr Renata Veraljai was the first to take the plunge with her Dissertation entitled ‘Application of circulation cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction of metastatic melanoma’.
Reni defended her dissertation in front of a panel of examiners on November 19th 2018 and passed with flying colours.
The second MELGEN ESR to submit his PhD Thesis entitled ‘Developing statistical and bioinformatic analysis of genomic data from tumours’ was Rohit Thakur from the University of Leeds. Rohit defended his research in a Viva on 7th December and also passed with flying colours.
Everyone in the MELGEN network congratulates Dr Varaljai and Dr Thakur on their fantastic achievement and valuable contribution to melanoma reseach, and wishes them both every success for their future careers.